Jinhe Biotechnology CO., LTD. (SHE:002688)
China flag China · Delayed Price · Currency is CNY
5.36
+0.14 (2.68%)
Aug 20, 2026, 3:04 PM CST

SHE:002688 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
838.02618.35635.89608.13491.37517.66
Trading Asset Securities
1.221.380.550.51--
Cash & Short-Term Investments
839.24619.74636.45608.64491.37517.66
Cash Growth
36.01%-2.63%4.57%23.87%-5.08%64.44%
Accounts Receivable
634.47656.18659.9633.13504.86493.6
Other Receivables
117.8746.1616.5364.7912.1211.22
Receivables
752.35702.34676.43697.92516.98504.82
Inventory
725.32668.1635.28670.55675.91577.2
Prepaid Expenses
-1.850.230.20.250.31
Other Current Assets
78.1765.8172.3262.2762.0149.97
Total Current Assets
2,3952,0582,0212,0401,7471,650
Property, Plant & Equipment
2,3392,3702,3222,0521,6231,209
Long-Term Investments
12.1517.1617.1612.163.150.53
Goodwill
279.92282.11460.3497.95298.91295.97
Other Intangible Assets
614.85631.15639.94656.4629.72645.33
Long-Term Deferred Tax Assets
51.6450.7771.2150.0516.549.99
Long-Term Deferred Charges
77.1875.4392.12102.4388.3275.35
Other Long-Term Assets
47.6534.927.0342.98102.16178.59
Total Assets
5,8175,5195,6515,4544,5094,065

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
220.61298.57313.71254.91263.11122.04
Accrued Expenses
27.2252.0672.8499.6247.436.65
Short-Term Debt
670.62730.351,0321,6871,246833.9
Current Portion of Long-Term Debt
760.2465.81225.3782.3144.7985.24
Current Portion of Leases
-116.9575.827.136.561.95
Current Income Taxes Payable
22.183.2321.971.11.235.21
Current Unearned Revenue
18.0924.7417.9617.7725.6630.61
Other Current Liabilities
126.42110.46101.16107.7829.4248.08
Total Current Liabilities
1,8451,8021,8612,2571,6651,164
Long-Term Debt
1,127992.34965.79497.49296.2287
Long-Term Leases
180.4113.01154.6426.197.67-
Long-Term Unearned Revenue
57.6359.0956.1239.2438.0938.33
Long-Term Deferred Tax Liabilities
107.2108.99112.97116.8876.667.38
Other Long-Term Liabilities
-----11.64
Total Liabilities
3,3183,0763,1512,9372,0831,368

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
769.5769.53771.69780.42780.42780.42
Additional Paid-In Capital
877.94875.99879.51896.48888.961,079
Retained Earnings
730.59668.29715.52690.64679.56603.94
Treasury Stock
-94.16-94.28-138.86-131.89-131.89-
Comprehensive Income & Other
1.198.8718.7511.144.61-25.2
Total Common Equity
2,2852,2282,2472,2472,2222,438
Minority Interest
214.34214.94253.25269.89203.63258.28
Shareholders' Equity
2,4992,4432,5002,5172,4252,696
Total Liabilities & Equity
5,8175,5195,6515,4544,5094,065

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
2,7392,4182,4542,3001,6021,008
Net Cash (Debt)
-1,899-1,799-1,818-1,691-1,110-490.44
Net Cash Growth
------
Net Cash Per Share
-2.44-2.30-2.35-2.17-1.42-0.70
Filing Date Shares Outstanding
769.1755.68752.17753.75753.75780.42
Total Common Shares Outstanding
769.1755.71752.17753.75753.75780.42
Working Capital
549.74255.66159.49-217.7481.88486.27
Book Value Per Share
2.972.952.992.982.953.12
Tangible Book Value
1,3901,3151,1461,0921,2931,497
Tangible Book Value Per Share
1.811.741.521.451.721.92
Buildings
-1,2621,204918.97806.47671.81
Machinery
-2,2492,0321,5861,5151,145
Construction In Progress
-195.5246.27645.56300.79289.91